Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis.

  • Authors : Alshehri AM; Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.

Subjects: Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/mortality ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/adverse effects

  • Source: BMC infectious diseases [BMC Infect Dis] 2025 Jan 07; Vol. 25 (1), pp. 36. Date of Electronic Publication: 2025 Jan 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

×
Academic Journal

The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa.

  • Authors : Barzilai A; Department of Dermatology, Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Tel Aviv University, Tel Aviv, Israel.; Institute of Pathology, Sheba Medical Center, Ramat-Gan, Israel.

Subjects: Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/drug therapy ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use

  • Source: The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2363318. Date of Electronic Publication: 2024 Aug 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Academic Journal

A targeted likelihood estimation comparing cefepime and piperacillin/tazobactam in critically ill patients with community-acquired pneumonia (CAP).

  • Authors : Serrano-Mayorga CC; Unisabana Center for Translational Science, Universidad de La Sabana, Chía, Colombia.; School of Medicine, Universidad de La Sabana, Chía, Colombia.

Subjects: Cefepime*/Cefepime*/Cefepime*/therapeutic use ; Cefepime*/Cefepime*/Cefepime*/administration & dosage ; Community-Acquired Infections*/Community-Acquired Infections*/Community-Acquired Infections*/drug therapy

  • Source: Scientific reports [Sci Rep] 2024 Jun 11; Vol. 14 (1), pp. 13392. Date of Electronic Publication: 2024 Jun 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Report

Piperacillin-tazobactam as the unusual cause of fever in a young male with an amoebic liver abscess.

  • Authors : Mangal V; Department of Internal Medicine, Military Hospital, Ambala, Haryana, India.; Singh R

Subjects: Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/therapeutic use ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/adverse effects ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/adverse effects

  • Source: Indian journal of pharmacology [Indian J Pharmacol] 2024 Mar 01; Vol. 56 (2), pp. 144-145. Date of Electronic Publication: 2024 Apr 30.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

×
Report

PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock (PAACS)

  • Source: Pharmacokinetics and Pharmacodynamic (PK/PD) of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of

تفاصيل العنوان

×
Report

Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity

  • Authors : Benoit Crevier, Principal Investigator

  • Source: Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity: an Open Randomized

تفاصيل العنوان

×
Academic Journal

Risk of kidney injury in patients on concomitant oral vancomycin and piperacillin-tazobactam: Analysis of the pharmacovigilance database in Japan.

Subjects: Acute Kidney Injury/Acute Kidney Injury/Acute Kidney Injury/*chemically induced ; Piperacillin, Tazobactam Drug Combination/Piperacillin, Tazobactam Drug Combination/Piperacillin, Tazobactam Drug Combination/*adverse effects ; Vancomycin/Vancomycin/Vancomycin/*adverse effects

  • Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2022 Jan; Vol. 130 (1), pp. 208-212. Date of Electronic Publication: 2021 Nov 30.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

تفاصيل العنوان

×
Report

Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers. (PROBATAZO)

  • Source: Antimicrobial Therapy for Ventilator-associated Pneumonia Among Patients Colonized With Extended-spectrum Beta-lactamase-producing Enterobacteriaceae : Efficacy of a Strategy Using

تفاصيل العنوان

×
  • 1-10 ل  708 نتائج ل ""piperacillin/tazobactam""